Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- NASDAQ Technical Picture - Narrow Range Day
May 21, 2008 02:00 AM
- FDA Extends Review Of NDA For Entereg To May 10
Feb 08, 2008 04:38 PM
- FDA Extends Review Of NDA For Entereg To May 10
Feb 08, 2008 04:38 PM
- Calling A Bottom
Jan 24, 2008 10:46 AM
- NASDAQ Technical Picture - High Volume Shake Out
Jan 23, 2008 11:57 PM
- Adolor,Glaxo:Majority Of FDA Panel Voted Favorably On Entereg
Jan 23, 2008 05:52 PM
- 2nd UPDATE: FDA Panel Backs Adolor/Glaxo GI Drug On 9-6 Vote
Jan 23, 2008 05:12 PM
- UPDATE: FDA Panel Backs Adolor/Glaxo GI Drug On 9-6 Vote
Jan 23, 2008 04:55 PM
- FDA Panel Backs Adolor/Glaxo GI Drug On 9-6 Vote
Jan 23, 2008 04:07 PM
- Daily Options Report
Jan 22, 2008 12:26 PM
- Study Published in Archives of Surgery Demonstrated Benefit of
ENTEREG® (alvimopan) in Postoperative Ileus
Nov 18, 2008 07:09 AM
- Adolor Corporation Reports Third Quarter 2008 Financial Results
Oct 28, 2008 07:35 AM
- Adolor Appoints John M. Limongelli as Senior Vice President, General Counsel and Secretary
Sep 10, 2008 09:31 AM
- Adolor Regains Rights to Entereg(R) (alvimopan) for OBD
Sep 02, 2008 09:04 AM
- Adolor Corporation Reports Second Quarter 2008 Financial Results
Aug 05, 2008 04:44 PM
- BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX
Jul 25, 2008 09:20 AM
- Adolor Provides Entereg(R) (Alvimopan) Hospital Registration Update
Jul 24, 2008 07:35 AM
- Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
Jul 03, 2008 07:31 AM
- Adolor Corporation Appoints Stephen W. Webster as Senior Vice President, Finance and Chief Financial Officer
Jun 13, 2008 03:02 PM
- Adolor Corporation Names Dr. Guido Magni to the Board of Directors
Jun 10, 2008 09:18 AM
- Form 4 ADOLOR CORP For: Oct 29 Filed by: BVF INVESTMENTS LLC (10K)
Oct 31, 2008 06:13 PM
- Form 4 ADOLOR CORP For: Oct 27 Filed by: BVF INC/IL (10K)
Oct 29, 2008 06:29 PM
- Form 4 ADOLOR CORP For: Oct 22 Filed by: BIOTECHNOLOGY VALUE FUND L P (10K)
Oct 24, 2008 06:03 PM
- Form 4 ADOLOR CORP For: Oct 15 Filed by: BVF INVESTMENTS LLC (10K)
Oct 17, 2008 05:46 PM
- Form 4 ADOLOR CORP For: Oct 13 Filed by: BVF INC/IL (10K)
Oct 15, 2008 06:42 PM
- Form 3 ADOLOR CORP For: Oct 10 Filed by: BVF INC/IL (10K)
Oct 15, 2008 05:41 PM
- Form 4 ADOLOR CORP For: Sep 18 Filed by: Limongelli John M (10K)
Sep 19, 2008 12:16 PM
- Form 3 ADOLOR CORP For: Sep 18 Filed by: Limongelli John M (10K)
Sep 19, 2008 11:58 AM
- Form 4 ADOLOR CORP For: Aug 11 Filed by: NICKELSON DONALD E (10K)
Aug 13, 2008 03:14 PM
- Form 3 ADOLOR CORP For: Jun 23 Filed by: Webster Stephen W (10K)
Jun 24, 2008 04:45 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
ADLR
|
Compare to S&P
|
| YTD |
-58.91 %
|
-32.69 %
|
| 4 Weeks |
-40.00 %
|
-35.15 %
|
| 12 Weeks |
-38.24 %
|
-14.39 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -281.25 %
|
|
EPS Growth in Last Year: 0.00 %
|
|
Sales Growth in Last Quarter: -70.81 %
|
|
Sales Growth in Last Quarter: 332.42 %
|
|
|
